Terence Flynn
Stock Analyst at Morgan Stanley
(2.11)
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
ALMS Alumis | Maintains: Overweight | 23 22 | 4.34 | 406.91% | 2 | Aug 15, 2025 | |
BHVN Biohaven | Maintains: Overweight | 63 54 | 13.43 | 302.08% | 3 | Aug 12, 2025 | |
PFE Pfizer | Maintains: Equal-Weight | 32 33 | 24.61 | 34.09% | 18 | Aug 6, 2025 | |
AMGN Amgen | Maintains: Equal-Weight | 330 333 | 285.1 | 16.8% | 9 | Aug 6, 2025 | |
ABBV AbbVie | Maintains: Overweight | 250 255 | 198.62 | 28.39% | 17 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 171 176 | 173.87 | 1.23% | 23 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 17 16 | 9.64 | 65.98% | 5 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 51 54 | 36.2 | 49.17% | 12 | Jul 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 99 98 | 80.06 | 22.41% | 17 | Jul 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 36 34 | 45.94 | -25.99% | 11 | Jul 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 132 133 | 109.29 | 21.69% | 4 | Jul 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 1133 1135 | 635.48 | 78.61% | 20 | Jul 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 348 328 | 300.44 | 9.17% | 10 | Jul 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 12 11 | 6.58 | 67.17% | 9 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 24 22 | 9.17 | 139.91% | 6 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 15 10 | 9.02 | 10.86% | 10 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 30 32 | 55.44 | -42.28% | 7 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 56 11 | 10.75 | 2.33% | 5 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 118 | 17.5 | 574.29% | 1 | Sep 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 121 168 | 129.46 | 29.77% | 6 | May 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 1 8 | 2.42 | 230.58% | 5 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 25 12 | 3.65 | 228.77% | 9 | Oct 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 2880 | 16.35 | 17514.68% | 1 | Jul 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 246 436 | 128.03 | 240.55% | 3 | Jun 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 35 | n/a | n/a | 1 | Jun 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 342 | n/a | n/a | 1 | Oct 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Neutral | 54 | 178.75 | -69.79% | 3 | May 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | n/a | n/a | n/a | 2 | Oct 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | Jul 21, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | Mar 13, 2017 |